Abstract:Background: In recent years clinical evidence has emphasized the importance of the mtDNA genetic background that hosts a primary pathogenic mutation in the clinical expression of mitochondrial disorders, but little experimental confirmation has been provided. We have analyzed the pathogenic role of a novel homoplasmic mutation (m.15533 A>G) in the cytochrome b (MT-CYB) gene in a patient presenting with lactic acidosis, seizures, mild mental delay, and behaviour abnormalities. Methodology: Spectrophotometric analyses of the respiratory chain enzyme activities were performed in different tissues, the whole muscle mitochondrial DNA of the patient was sequenced, and the novel mutation was confirmed by PCR-RFLP. Transmitochondrial cybrids were constructed to confirm the pathogenicity of the mutation, and assembly/stability studies were carried out in fibroblasts and cybrids by means of mitochondrial translation inhibition in combination with blue native gel electrophoresis. Principal findings: Biochemical analyses revealed a decrease in respiratory chain complex III activity in patient's skeletal muscle, and a combined enzyme defect of complexes III and IV in fibroblasts. Mutant transmitochondrial cybrids restored normal enzyme activities and steady-state protein levels, the mutation was mildly conserved along evolution, and the proband's mother and maternal aunt, both clinically unaffected, also harboured the homoplasmic mutation. These data suggested a nuclear genetic origin of the disease. However, by forcing the de novo functioning of the OXPHOS system, a severe delay in the biogenesis of the respiratory chain complexes was observed in the mutants, which demonstrated a direct functional effect of the mitochondrial genetic background. Conclusions: Our results point to possible pitfalls in the detection of pathogenic mitochondrial mutations, and highlight the role of the genetic mtDNA background in the development of mitochondrial disorders.

In-depth study of MPV17: a molecular travel unveiling a mitochondrial calcium regulation function

MIRO-1 interacts with VDAC-1 to regulate mitochondrial membrane potential in <i>Caenorhabditis elegans</i>

Voltage-dependent Anion Channel Involved in the Mitochondrial Calcium Cycle of Cell Lines Carrying the Mitochondrial DNA A4263G Mutation.

MPV17 mutation causes neuropathy and leukoencephalopathy with multiple mtDNA deletions in muscle

The mitochondrial inner membrane protein MPV17 prevents uracil accumulation in mitochondrial DNA

Mpv17 in Mitochondria Protects Podocytes Against Mitochondrial Dysfunction and Apoptosis in Vivo and in Vitro.

Decoding the mitochondria without a code: mechanistic insights into mitochondrial DNA depletion syndromes

Mitochondrial protein MPV17 promotes (3-cell apoptosis in diabetogenesis

Molecular Basis of the Pathogenic Mechanism Induced by the m.9191T>C Mutation in Mitochondrial ATP6 Gene

Mitochondrial Protein MPV17 Promotes Β-Cell Apoptosis in Diabetogenesis.

Impact of the mitochondrial genetic background in complex III deficiency

Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion

Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients

Engineering mtDNA Deletions by Reconstituting End-Joining in Human Mitochondria

Genetic mosaic analysis of a deleterious mitochondrial DNA mutation in Drosophila reveals novel aspects of mitochondrial regulation and function.

Loss-of-function mutations in MICU 1 cause a brain and muscle disorder linked to primary alterations in mitochondrial Ca 2 + signalling

Two mitochondrial DNA polymorphisms modulate cardiolipin binding and lead to synthetic lethality

Capture of Somatic mtDNA Point Mutations with Severe Effects on Oxidative Phosphorylation in Synaptosome Cybrid Clones from Human Brain

The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter

Preliminary Findings of a Proteomic Approach

Mutation in the MICOS subunit gene APOO (MIC26) associated with an X-linked recessive mitochondrial myopathy, lactic acidosis, cognitive impairment and autistic features